Beijing Wehand-bio Pharmaceutical Co., Ltd
Clinical trials sponsored by Beijing Wehand-bio Pharmaceutical Co., Ltd, explained in plain language.
-
New chemo combo shows promise in breast cancer trial
Disease control CompletedThis study tested a new chemotherapy drug called WH002 against the standard drug paclitaxel in 40 women with HER2-negative breast cancer. Both drugs were given before surgery, followed by two other chemotherapy drugs. The main goal was to compare side effects and how well the tum…
Phase: PHASE2 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Mulberry extract tested for weight management safety
Knowledge-focused CompletedThis early-stage study tested a tablet made from mulberry twig alkaloids (WH006) in 62 healthy and overweight/obese adults in China. The main goal was to check safety and how the drug moves through the body. Researchers measured side effects and drug levels after single doses, co…
Phase: PHASE1 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC